Проведен расширенный анализ иммунных параметров, характеризующих дифференцировку, активацию и истощение лимфоцитов, моноцитов и гранулоцитов у пациентов со среднетяжелой и тяжелой пневмонией COVID-19.
Бобрукевич Д. , Антоневич Н. , Гончаров А. , Рында Е. , Тимохина О. , Минич Я. , Головач Е. , Доценко М. , Доценко Э. Новые биомедицинские клеточные продукты для иммунотерапии заболеваний человека. Наука и инновации. 2022;(2):24-35.
https://doi.org/10.29235/1818-9857-2022-2-24-35
1. Sustained cellular immune dysregulation in individuals recovering from SARS CoV 2 infection / Files J. K. [et al.] // The Journal of Clinical Investigation. 2020. №1. P. 131
2. Coronavirus infections and immune responses / Li G. [et al.] // Journal of medical virology. 2020. V. 92. №4. P. 424–432.
3. The clinical course and its correlated immune status in COVID 19 pneumonia / Ruyuan He. [et al.] // Journal of Clinical Virology. 2020. №7. P. 127.
4. De Virgiliis, F. Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID 19 / De Virgiliis F., Di Giovanni S. // Nature Reviews Neurology. 2020. №11, Vol. 16. P. 1–8.
5. Characteristics of peripheral lymphocyte subset alteration in COVID 19 pneumonia / Wang F. [et al.] // The Journal of infectious diseases. 2020. V. 221. №11. P. 1762–1769.
6. Phenotype of SARS CoV 2 specific T cells in COVID 19 patients with acute respiratory distress syndrome / Weiskopf D. [et al.] // Sci Immunol. 2020. V. 5. №48. eabd2071
7. Detection of SARS CoV 2 specific humoral and cellular immunity in COVID 19 convalescent individuals / Ling Ni. [et al.] // Immunity. 2020. V. 52. №6. P. 971–977.
8. Suppressed T cell mediated immunity in patients with COVID 19: a clinical retrospective study in Wuhan, China / Bo Xu. [et al.] // The Journal of infection. 2020. V. 81. №1. P. 51–60.
9. SARS CoV 2 reactive T cells in healthy donors and patients with COVID 19 / Braun J. [et al.] // Nature. 2020. №578. P. 270–274.
10. In depth phenotyping of human peripheral blood mononuclear cells in convalescent COVID 19 patients following a mild versus severe disease course / Chang Feng Chu. [et al.] // medRxiv. 2020.
11. Shared Antigen specific CD8+ T cell Responses Against the SARS COV 2 Spike Protein in HLA A* 02: 01 COVID 19 Participants / Chour W. [et al.] // medRxiv. 2020.
12. SARS CoV 2, the virus that causes COVID 19: cytometry and the new challenge for global health / Cossarizza A. [et al.] // Cytometry. 2020. V. 97. №4. P. 340–343.
13. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID 19) / Diao B. [et al.] // Frontiers in Immunology. 2020. №11. P. 827.
